MARY KALLMEYER F-NP
Prescription History 1245705607
Nurse Practitioner - Family in Middletown, NY

Active since October 11, 2018PECOS EnrolledAccepts Medicare Assignment
111 MALTESE DR, MIDDLETOWN, NY 10940(845) 342-4774 Get Directions

NPPES record last updated: October 11, 2018. Verified against the NPPES registry weekly; last sync: August 23, 2026.

Medicare Part D Prescription History

Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for MARY KALLMEYER F-NP, an active Family specialist practicing in Middletown, NY. Our medical registry currently tracks 1 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 14 documented patient claims. Among these therapy options, the most frequently utilized medication is Raloxifene Hcl, which accounts for 14 claims alone. Use the table below to sort by claims, cost, or utilization compared with the state average; select any medication for its full profile.

1
Medication
14
Total Claims
42
30-Day Fills
Raloxifene Hcl
Most Prescribed · 14 claims
View details
1 medication · 2023 Medicare Part D
Medicare Part D medications prescribed by MARY KALLMEYER F-NP in 2023, with prescription volumes, average cost per fill, and NY state comparisons
Medication Prescriptions (2023)Rx (2023) Avg Cost per FillCost / Fill Vs. Other NY PrescribersVs. NY Avg
Raloxifene Hcl14$61.92▼ below NY avg Less than typical

About Raloxifene Hcl: Raloxifene is used by women to prevent and treat bone loss (osteoporosis) after menopause. Show more ▾

It slows down bone loss and helps to keep bones strong, making them less likely to break. Raloxifene may also lower the chance of getting a certain type of breast cancer (invasive breast cancer) after menopause. Raloxifene is not an estrogen hormone, but it acts like estrogen in some parts of the body, like your bones. In other parts of the body (uterus and breasts), raloxifene acts like an estrogen blocker. It does not relieve menopause symptoms such as hot flashes. Raloxifene belongs to a class of drugs known as selective estrogen receptor modulators-SERMs. This medication should not be used before menopause. It should not be used to prevent heart disease. A second generation selective estrogen receptor modulator (SERM) used to prevent osteoporosis in postmenopausal women. It has estrogen agonist effects on bone and cholesterol metabolism but behaves as a complete estrogen antagonist on mammary gland and uterine tissue.

In 2023, this provider wrote 14 Medicare prescriptions for Raloxifene Hcl, about a quarter of the volume of the typical New York prescriber of this medication (54). Medicare paid an average of $61.92 per fill, versus $73.82 statewide.

How often this provider prescribes it

This provider
14
NY average
54.0

This provider prescribes this medication less often than the average NY prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$61.92
NY average
$73.82

This provider's average cost per fill is below the NY average for this medication.

42
30-Day Fills
standardized to 30-day supplies
1,260
Days of Medication
total across all patients in 2023
No medications match the current filters.
More than typical Typical Less than typical= prescription volume vs the average NY prescriber of the same medication; volume reflects practice size as well as clinical preference.Green cost= below the NY average cost per fill.

About this data. The prescription history for MARY KALLMEYER F-NP is compiled from the Centers for Medicare & Medicaid Services (CMS) Medicare Part D Prescriber Public Use File for calendar year 2023, the most recent federal release. Figures cover prescriptions filled for Medicare Part D beneficiaries only; prescriptions under private insurance, Medicaid, or self-pay plans are not included. Because prescribing decisions are generally consistent across coverage types, this record offers a useful view of the overall Family prescribing approach at this Middletown, NY practice.

Reading the costs. Drug costs are gross amounts paid to pharmacies under Part D, including both plan and beneficiary payments. They are not the price a patient pays at the pharmacy counter. Medications with fewer than 11 claims are excluded from the federal source data, and state comparisons use the average volume among NY prescribers of the same medication. Always confirm current medications and costs directly with the provider and your plan.